ABVC BioPharma, Inc. (ABVC)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Sep 30, 2015	Sep 30, 2013	Sep 30, 2012
New Drugs and Medical Devices	152.43K
New Drugs and Medical Devices Growth	-84.28%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Sep 30, 2015	Sep 30, 2013	Sep 30, 2012
United States	152.43K
United States Growth	-84.28%